European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
Comparative findings of oncogenic cervical risk and its follow-up in two different periods 1982-1999 and 2000-2007
1 National Association Against Cancer (ANCEC), Social Security Foundation (CSS), Panama City (Panama)
Eur. J. Gynaecol. Oncol. 2010, 31(5), 559–561;
Published: 10 October 2010
During the 2000-2007 period, my group and I reviewed the cases of 3,036 patients undergoing routine colposcopies, cytology and cervical biopsies for those cases that merited it, and a 20% increase was found in lesions defined as dysplasias as compared with those found in the studies of the previous century. This is something that reaffirms the association with HPV by 96.5% versus 80% the last century. In relation to HPV infection, we found that the “pure” form was not only reached but rather surpassed by the findings associated with cancer and dysplasia in the years 2005-2006, a behavior considered irregular as compared to the usual. The majority of the patients were guided toward conservative local treatments, among which cryosurgery and cauterization prevailed as choices, and their evolution resulted in an 81% cure (considered as destruction of the lesion and negativity of the cytology and eventual biopsy). It can be concluded that the high vulnerability of the virus, in spite of its great aggressiveness as an oncogenic risk (OR) to a cervical-uterine lesion, can be supported by the high degree of lesions diagnosed by OR.
Degree of pathology